Skip to main
LUCD
LUCD logo

Lucid Diagnostics (LUCD)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Lucid Diagnostics (LUCD) Stock

About Lucid Diagnostics (LUCD)

Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. The company was founded by Lishan Aklog on May 8, 2018 and is headquarter...read more
Market cap$139.57M
Today's volume744.91K
Revenue (TTM)$4.17M
Avg. daily volume1.2M
EBITDA (TTM)-$46.86M
Open$1.32
Price / earnings ratio-1.08x
Today's range$1.28 - $1.34
Debt / equity
52 week range$0.68 - $1.8
5 year debt / equity5.86x
Beta (LTM)0.76x
Interest coverage-1771.23x
Dividend & yield$0.00 (0.00%)
Current ratio0.75x
Ex-dividend date
Next earningsAug 11, 2025
Dividend payable date

Lucid Diagnostics Stock Rating

What analysts recommend for LUCD stock, on a scale from 1(buy) to 5(sell).
Strong Buy
Strong Buy 80%
Buy 20%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 15, 2025, the market cap for LUCD stock is $139.58M

The current P/E ratio for LUCD stock is -1.08

The 52-week high for LUCD stock is $1.80. The current LUCD stock price $undefined is 100.00% below its 52-week high

The 52-week low for LUCD stock is $0.68. The current LUCD stock price $undefined has increased 100.00% from its 52-week low

No, the LUCD stock does not pay dividends to its shareholders

The target price for LUCD stock is $3.85 based on the average of what a group of analyst think LUCD stock could be worth at a future date. This is not a prediction by Public.com

How to buy LUCD stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in LUCD stock

    Navigate to the Explore page. Then, type LUCD into the search bar. When you see LUCD stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased LUCD stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Lucid Diagnostics Stock Earnings

The value each LUCD share was expected to gain vs. the value that each LUCD share actually gained.

Lucid Diagnostics (LUCD) reported Q1 2025 earnings per share (EPS) of -$0.16, missing estimates of -$0.10 by 60.00%. In the same quarter last year, Lucid Diagnostics's earnings per share (EPS) was -$0.21. Lucid Diagnostics is expected to release next earnings on 08/11/2025, with an earnings per share (EPS) estimate of $0.

Buy Lucid Diagnostics (LUCD) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.